Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Disclosures and funding
- Collaborators
- Plan of presentation
- Diabetes spectrum
- Assessing the spectrum
- C-peptide fall by age and T1D duration
- Adult-onset autoimmune diabetes
- Disease incidence and age of onset
- Autoimmune diabetes in adults
- GADA: disease outcome prediction
- Adult-onset diabetes: EPIC-InterAct cohort
- Clinical utility of T1D GRS with GADA
- Latent autoimmune diabetes in adults GWAS
- Challenges in diagnosis
- Utility of classifying diabetes
- Adult-onset diabetes: Swedish cohort
- Thyroid autoimmunity
- Management of adult autoimmune diabetes
- Management II
- Summary of presentation
Topics Covered
- Autoimmune diabetes
- Adult-onset diabetes
- Non-insulin requiring diabetes
- Type 1 diabetes
- The diabetes spectrum
- C-peptide
- GADA
- Managing adult-onset diabetes
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Leslie, R.D. (2021, October 31). Autoimmune diabetes in adults: current evidence and controversies [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 22, 2024, from https://doi.org/10.69645/WQTB1242.Export Citation (RIS)
Publication History
Financial Disclosures
- The speaker sits on the advisory board for Abbott, Sanofi, Roche, Novo-Nordisk and Diamyd. He receives funding from the EU, EFSD, Barts Charity and Diabetic Twin Trust.
A selection of talks on Clinical Practice
Transcript
Please wait while the transcript is being prepared...
0:00
Hello, my name is David Leslie.
I'm going to talk to you about autoimmune diabetes in adults,
current evidence and controversies.
I work at the Blizard Institute in Barts at the University of London.
0:18
These are my disclosures and funding.
0:23
This work I'm describing has been done by many people around the world,
both in my department as well as in Europe, in China, in America,
and the people who have been particularly helpful in this collaborative process are shown here,
though there are many others who are not included.
0:47
The plan of his presentation is four-fold:
the nature of autoimmune disease;
describing the immunogenetic features of disease;
the non-genetic effects associated with disease;
and the clinical utility of identifying autoimmune disease.
Here I'm using autoimmune disease as a general feature,
but I'm specifically interested in the autoimmune disease known as type 1 diabetes.
1:18
Type 1 diabetes is a form of diabetes with a high blood sugar
associated with a striking spectrum of diabetes, which ranges from juvenile onset to old age.
The more you get older, the less likely you are to require insulin treatment.
It was nearly 100 years ago that diabetes was diagnosed in a child who received insulin, and survived.
In those days, this was seen as a lethal childhood-onset disease,
and became known as 'insulin-dependent diabetes',
and subsequently type 1 diabetes.
The other type, the type that did not require insulin,
was known as 'maturity-onset diabetes', and more recently type 2 diabetes.
However, the distinction between these two is entirely confined to
the features associated with type 1 (insulin-dependent) diabetes.
Over the years it's become apparent the distinction is not quite as categorical as it would appear.
We now think of autoimmune diabetes extending across the age range,
and I'll show you, indeed, that the most common form of this type 1 diabetes is in adult life,
presenting as an adult, and often not requiring insulin - at least initially.